HealthLynked Corp.
Income Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $2.1M | $3.0M | $5.7M | $5.9M | $6.5M | $6.1M | $4.0M | $2.3M |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| Gross Margin | — | — | — | — | — | — | — | — |
| Operating Expenses | ||||||||
| Research & Development | — | — | — | — | — | — | — | — |
| SG&A Expense | $2.0M | $3.0M | $3.6M | $4.6M | $4.9M | $3.1M | $2.9M | $2.8M |
| Operating Income | $-2.1M | $-4.7M | $-4.2M | $-8.7M | $-5.3M | $-3.1M | $-3.2M | $-3.0M |
| Operating Margin | -102.3% | -155.5% | -72.6% | -147.8% | -82.1% | -50.1% | -79.8% | -131.6% |
| Interest Expense | — | — | $21.3K | $0 | — | — | $244.1K | $193.1K |
| Pretax Income | — | $-6.1M | $-3.6M | $-8.1M | $-10.7M | $-5.8M | $-5.5M | $-5.8M |
| Income Tax Expense | — | — | — | — | — | — | — | — |
| Net Income | $-3.3M | $-6.1M | $-1.0M | $-8.8M | $-10.4M | $-5.8M | $-5.5M | $-5.8M |
| Net Margin | -158.8% | -203.8% | -17.7% | -150.5% | -160.3% | -93.8% | -137.6% | -256.3% |
| EPS (Basic) | $-1.16 | $-2.18 | $0.00 | $-0.04 | $-0.05 | $-0.04 | $-0.06 | $-0.07 |
| EPS (Diluted) | $-1.16 | $-2.18 | $0.00 | $-0.04 | $-0.05 | $-0.04 | $-0.06 | $-0.07 |
| Shares Outstanding (Basic) | 2.8M | 2.8M | 262.9M | 243.4M | 224.7M | 142.8M | 99.1M | 78.8M |
| Shares Outstanding (Diluted) | 2.8M | 2.8M | 262.9M | 243.4M | 224.7M | 142.8M | 99.1M | 78.8M |
| Dividends Per Share | — | — | — | — | — | — | — | — |